Brien, Gerard L. http://orcid.org/0000-0003-4275-7178
Stegmaier, Kimberly
Armstrong, Scott A. http://orcid.org/0000-0002-9099-4728
Article History
First Online: 8 April 2019
Competing interests
: S.A.A. is a consultant and/or shareholder for Epizyme, Imago Biosciences, Cyteir Therapeutics, C4 Therapeutics, Syros Pharmaceuticals, OxStem Oncology, Accent Therapeutics and Mana Therapeutics. K.S. has consulted for Novartis and Rigel Pharmaceuticals. The Armstrong laboratory has received research support from Janssen, Novartis and AstraZeneca. The Stegmaier laboratory receives grant support from Novartis. G.L.B. declares no competing interests.